ω-carboxyl aryl substituted diphenyl ureas as p38 kinase inhibitors

  • US 7,897,623 B2
  • Filed: 08/27/2007
  • Issued: 03/01/2011
  • Est. Priority Date: 01/13/1999
  • Status: Expired due to Term
First Claim
Patent Images

1. A pharmaceutical composition comprising N-(4-chloro-3-(trifluoromethyl)phenyl)-N′

  • -(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea of the formula X

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×